Aspen Targets Further Chinese Acquisitions After Glaxo Deal

  • South African drugmaker boosts salesforce to 700 in expansion
  • Shares reverse losses; plunged after profit warning Sept. 8

Aspen Pharmacare Holdings Ltd. is seeking further acquisitions and adding salespeople in China as Africa’s biggest maker of generic drugs targets the world’s most populous country as a major growth market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.